An immunomodulatory peptide derived from the thymus gland, approved in several countries for hepatitis B/C and studied for immune enhancement in cancer and infectious diseases.
Cancer biology & medicine|2023|Liu Q et al.|7 citations
Cancer remains a significant global health challenge with limited treatment options beyond systemic therapies, such as chemotherapy, radiotherapy, and molecular targeted therapy. Immunotherapy has emerged as a promising therapeutic modality but the e…
Review
PMID: 37929901
International immunopharmacology|2023|Ricci D et al.|7 citations
The peculiar property of Thymosin alpha 1 (Tα1) to act as master regulator of immune homeostasis has been successfully defined in different physiological and pathological contexts ranging from cancer to infection. Interestingly, recent papers also de…
In Vitro
PMID: 36933449
Molekuliarnaia biologiia|2023|Novoselova E et al.|3 citations
The aim of this work was to study the effects of thymosin-1 alpha (Tα1) on the anti-inflammatory response of RAW 264.7 macrophages cultured in the presence of lipopolysaccharide (LPS) from the walls of gram-negative bacteria. As well, we evaluated pr…
In Vitro
PMID: 38062956
International immunopharmacology|2023|Espinar-Buitrago M et al.|5 citations
Tα1 (Thymosin-alpha-1) is a thymus-derived hormone that has been demonstrated to be effective on diverse immune cell subsets. The objective of this study was to determine the in vitro immunomodulatory effect of Tα1 in human cytomegalovirus (HCMV) inf…
In Vitro
PMID: 38149577
The Journal of infectious diseases|2023|Shehadeh F et al.|11 citations
BACKGROUND: Thymosin-α-1 (Tα1) may be a treatment option for coronavirus disease 2019 (COVID-19), but efficacy and safety data remain limited. METHODS: Prospective, open-label, randomized trial assessing preliminary efficacy and safety of thymalfasin…
PMID: 36056913
Panminerva medica|2023|Zhang Y et al.|4 citations
Animal Study
PMID: 32077672
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]|2023|Abdel-Karim T et al.|6 citations
BACKGROUND: In total pancreatectomy with islet auto-transplantation, successful diabetes outcomes are limited by islet loss from the instant blood mediated inflammatory response. We hypothesized that blockade of the inflammatory response with either…
Randomized Controlled Trial
PMID: 36443174
International immunopharmacology|2023|Shang W et al.|5 citations
OBJECTIVE: Thymosin alpha1 (Ta1) is widely used to treat patients with coronavirus disease 2019 (COVID-19), however, its effect remains unclear. This systematic review and meta-analysis aimed to evaluate the effect of Ta1 as a COVID-19 therapy. METHO…
ReviewMeta-Analysis
PMID: 36527881
Transplant infectious disease : an official journal of the Transplantation Society|2023|Wu Q et al.|4 citations
OBJECTIVE: This study aims to observe and analyze the clinical characteristics and prognosis of adenovirus (ADV) infection diagnosed by metagenomic next-generation sequencing (mNGS) after haploidentical hematopoietic stem cell transplantation (Haplo-…
PMID: 36908212
Journal of thrombosis and haemostasis : JTH|2023|Jiang L et al.|6 citations
BACKGROUND: T cells and platelets reciprocally coordinate mutual functions through crosstalk or interaction. However, it is not known whether metabolic activation of and platelet response to clopidogrel could be changed if T cells were deficient or i…
Animal Study
PMID: 36738827
International immunopharmacology|2023|Nevo N et al.|7 citations
BACKGROUND: Peritoneal metastases of colorectal carcinoma origin (PM-CRC) are treated by cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC). However, the majority of patients recur, calling for novel treatments. We explored the imm…
Animal Study
PMID: 36758296
International immunopharmacology|2023|Wei Y et al.|6 citations
Thymosin α-1 (Tα-1) is an immunomodulating polypeptide of 28 amino acids, which was the first peptide isolated from thymic tissue and has been widely used for the treatment of viral infections, immunodeficiencies, and especially malignancies. Tα-1 st…
PMID: 36812669
Open life sciences|2023|Zhang D et al.|2 citations
This study investigated the effect of combined thymosin α1 and vitamin C (Tα1 + VitC) on the immunological responses of septic rats. Five groups were designed. The septic model was established by the cecal ligation puncture (CLP) method. The sham gro…
Animal Study
PMID: 36816800
International immunopharmacology|2023|Mao L|5 citations
Thymosin alpha 1 (Tα1) is a highly conserved 28 amino-acid peptide naturally occurring in the thymus and plays critical roles in T cell maturity and differentiation. Its synthetic form, thymalfasin, has been approved by various regulatory agencies in…
PMID: 36871535
International immunopharmacology|2023|Bellet M et al.|6 citations
The recent COVID-19 pandemic has catalyzed the attention of the scientific community to the long-standing issue of lower respiratory tract infections. The myriad of airborne bacterial, viral and fungal agents to which humans are constantly exposed re…
Review
PMID: 36881979
International immunopharmacology|2023|Tuthill C et al.|3 citations
PURPOSE: Patients with end-stage renal disease (ESRD) on hemodialysis (HD) are considered particularly susceptible to infection with SARS-CoV2 on the basis of the immunodeficiency associated with advanced age, comorbidity burden, medication use, and…
Randomized Controlled Trial
PMID: 36881981
Expert opinion on therapeutic patents|2023|Quagliata M, Papini A, Rovero P|7 citations
INTRODUCTION: Thymosins are small proteins found mainly in the thymus. They are involved in several biological processes, including immunoregulation, angiogenesis, and anti-inflammatory activity. Due to these multiple activities, thymosins are widely…
Review
PMID: 38131310
International journal of radiation oncology, biology, physics|2022|Liu F et al.|22 citations
PURPOSE: To evaluate the efficacy of thymosin α1 in management of radiation pneumonitis (RP) in patients with locally advanced non-small cell lung cancer (LANSCLC) treated with concurrent chemoradiotherapy (CCRT). METHODS AND MATERIALS: This phase 2,…
Clinical Trial
PMID: 35870709
Alternative therapies in health and medicine|2022|Bai L et al.
CONTEXT: Septic shock (SS) can pose a high risk of death if rescue efforts in an emergency room aren't started in a timely manner. Thus, rapid and efficient treatment is of great significance to the SS patients' survival. T-α1 can enhance the cellula…
Randomized Controlled Trial
PMID: 35951068
International immunopharmacology|2022|Nevo N et al.|11 citations
INTRODUCTION: Heated intraperitoneal chemotherapy (HIPEC) is currently implemented in the treatment of peritoneal metastases from colorectal carcinoma (PM-CRC) origin. However, recurrence is common and the effectiveness of HIPEC has been questioned.…
Animal Study
PMID: 35994852